Fundz

Eclipse Bioinnovations, Inc. reported raising $12 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATESep 10, 2021$12M of $15M raised

Amount Raised

$12 Million

$12 Million sold, per SEC Form D (first sale Sep 10, 2021)

Round Type

Venture

San DiegoBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Eclipsebio that raised within 45 days of this round, from Fundz verified event records.

  • Aegis Spine, Inc. raised $1.1M (Seed) on October 25, 2021.
  • Vitranu, Inc. raised $1.5M (Seed) on October 25, 2021.
  • Bionano Genomics raised $42M on October 25, 2021.
  • ICaPath, Inc. raised $500K (Seed) on October 25, 2021.
  • Tessera Defense & Homeland Security Inc. raised $3M on October 25, 2021.
  • Anuncia Medical raised $14M on October 25, 2021.

Who to call at Eclipsebio, and when

A new round usually means Eclipsebio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eclipsebio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eclipsebio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eclipsebio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eclipsebio

Location

5770 Oberlin Dr

San Diego, California, United States

About

Eclipsebio is a private biotechnology company headquartered in San Diego developing first-in-class technologies, analytics, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies. With the company’s extensive experience in supporting early-stage basic research through to evaluating preclinical therapies, Eclipsebio provides unparalleled support for obtaining deep insights into RNA and therapeutic biology. The company offers its solutions as end-to-end partnerships for biopharma and project-based services for academics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eclipsebio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Eclipsebio's next move

See what Strategic adds

Eclipsebio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.